Searched for
BIOTECH CANCER TREATMENT
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- “Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Guardant Health to launch blood-based cancer test in India with Zydus LifesciencesGuardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, co-marketed by...
- Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...
- You thought only DeepSeek routed American titans? Wait, here's a little-known Chinese biotech company whose lung cancer drug could rattle big pharma; here's all about itChinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough si...
- Zydus Lifesciences inks licensing pact with Zhuhai for cancer drugZydus Lifesciences' subsidiary partners with Zhuhai Beihai Biotech to market Beizray, a cancer drug, in the US. Zhuhai will handle manufact...
- What to expect from US President Joe Biden's 'Cancer Moonshot' speech in Boston? Hints hereUS President Joe Biden will deliver a speech on the American revolutionary vision of cancer treatment and cure on Monday in Boston. His add...
- Mitra Biotech, Harvard unravels how to kill cancer cells that avoid chemotherapyThe method was to give another common drug just when the cancer cells begin to morph into a stem-cell like type that can avoid the chemo dr...
- Tata Capital to invest Rs 40 crore in Mitra biotechThe deal values the personalised oncology solution provider at about Rs 200 crore, according to a person with direct knowledge of the trans...
- Biotech drugs to replace chemical entities Lipitor & Plavix as market leadersThe global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.
- Actis Biologics starts phase-III trials of cancer drugBiotech firm Actis Biologics today said that Angiozyme, its biotech molecule targeted at colorectal cancer has entered into the third phase...
- Mitra Biotech gets VC fundingThe Bangalore-based Mitra Biotech, a biology research firm and spin-off from MIT, US, has received venture capital funding from Accel Partn...
- WB soon to have a world class research facility for cancerWest Bengal will soon house a world-class research facility for cancer.
- Biocon to partner US-based firm for developing cancer drugBiotech major Biocon Ltd on Thursday said it will enter into a partnership with a US-based biotechnology company, Iatrica, to develop drug ...
- Coming soon: Drugs to suit your genetic profileThe tests will initially be only for cancer patients and Mr Saxena’s company, Acton Biotech, plans to cover other diseases later.
Load More
